CYRX
Cryoport, Inc.
Cryoport runs temperature-controlled supply chains for the life sciences, specializing in shipping and storing cell and gene therapies in ultra-cold cryogenic conditions. Its MVE Biological Solutions makes the freezers, dewars, and transport systems, while services like Cryoport Express and BioStorage move and hold these delicate biological materials worldwide. The company was founded in 1999 by six doctors and went public in 2005 through a reverse merger. Its name blends "cryo," for freezing, with "port," a place of arrival and departure.
CUSIP: 229050307HealthcareUS1 holder
Total Value
$2.95M
Total Shares
46.8K
Net Share Change
+46.8K
Activity
1 buying
Investor
Value
Shares
Weight
Change
